Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of CONTRAVE in Obesity
NCT06809166Phase 4Recruiting
- Sponsor
- University of Ottawa Institute of Mental Health Research at The Royal
- Start
- Jul 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone + bupropion in obesity, sponsored by University of Ottawa Institute of Mental Health Research at The Royal. Started Jul 2024; status: recruiting.
02
Drugs
naltrexone + bupropion
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06809166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809166.